Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 3, 2024. (Total: 234028Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 3 (of 3 Records)

Query Trace: Anemia and ALK[original query]
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar .
Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib.
Cancer management and research 2019 11 8191-8200.
Liang Hongge, Ma Di, Xu Yan, Zhao Jing, Chen Minjiang, Liu Xiaoyan, Zhong Wei, Li Junling, Wang Mengzh
Evaluation of the efficacy of PD?1/PD?L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene?negative advanced?stage lung adenocarcinoma: A retrospective cohort study.
Oncology letters 2024 11 29 (1): 53.
Xiaozun Yang, Xin Li, Ke Huang, Xiang Zhua
TOP